2024-11-08T17:42:05-06:00 2023-12-31 475028428 Howard Sckolnik 8203 E Sierra Pinta Dr Scottsdale AZ 85255 990 2023-01-01 861221438 ALLIANCE FOR CELL THERAPY FOUNDATION % JANET MARCHIBRODA ALLI 2029229077 300 NEW JERSEY AVENUE NW Ste 900 WASHINGTON DC 20001 JANET MARCHIBRODA President 2029229077 2024-11-08 true false HOWARD SCKOLNIK P01064967 6025240974 2024-11-08 X 2023 2024-10-15 13:58:12Z JANET MARCHIBRODA 300 NEW JERSEY AVENUE NW Ste 900 WASHINGTON DC 20001 0 false X X 2020 DC Engage experts and patients and conduct research and education to support development of therapies for patients in need 4 4 0 0 175000 0 0 0 0 175000 0 0 0 0 0 0 167310 4567 167310 4567 7690 -4567 10175 817 6879 2088 3296 -1271 Engage experts and patients and conduct research and education to support development of therapies for patients in need. false false 600 1.In support of its goal to conduct research and education, the organization engaged experts and stakeholders in the field of cell- cell-based therapy, including researchers from academic, research, and industry organizations, and those representing patients, to assess the current state of the field; identify barriers to the development, translation, and manufacturing of safe and effective therapies; identify strategies and policies for addressing such barriers; and develop white papers outlining actions needed to advance the field. 2.In support of its goal to conduct research and education, the organization developed reports, white papers, briefs, and other com- communications materials and hosted virtual events featuring nationally recognized experts and scientists, as well as patients, to support charitable and educational purposes of the organization. 3.In support of its goal to provide educational resources to support patients, the organization made publicly available, guides to support patient decision-making related to cell-based therapies. 4.In support of its goal to expand the evidence base associated with cell-based therapies for patients in need, the organization analyzed clinical trials exploring the use of regenerative medicine and cell therapies for patients in need. 600 true false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false true false false false true 0 0 true 0 false false false false false false false false false false X 4 4 false false false false false false false true true false false true true true true true true true false false X Crosby Ottenhoff Group 2055334260 611 PENNSYLVANIA AVE SE Ste 267 WASHINGTON DC 20036 X JANET MARCHIBRODA PRESIDENTSECRETARY X X 0 0 0 MARIA MILLAN DIRECTOR X 0 0 0 KRISHNENDU ROY DIRECTOR X 0 0 0 FRED SANFILIPPO DIRECTORCHAIRMAN X X 0 0 0 MICHELE REISNER TREASURER X 0 0 0 false false false 0 0 X 970 970 1350 1350 1608 1608 39 39 600 600 4567 600 3967 0 10175 817 10175 817 6879 2088 6879 2088 X 3296 -1271 3296 -1271 10175 817 -4567 X false false false X 100000 175000 275000 100000 175000 275000 275000 275000 X 0.00000 Part VI Line 11b Prior to filing a draft of Form 990 is provided to members of the governing Part VI Line 11b body for their review and comments. Part VI Line 12c AT THE BOARDS ANNUAL MEETING AND AS SITUATIONS ARRISE THE BOARD Part VI Line 12c REVIEWS POTENTIAL CONFLICTS OF INTEREST. Part VI Line 18 THE ORGANIZATIONS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST Part VI Line 18 POLICY WILL BE MADE AVAILABLE UPON WRITTEN REQUEST. Part VI Line 19 These documents are not made available. Part IX Line 11g Compliance consulting Total expenses - $1608.00 Program service expenses - $0.00 Mgmt and general expenses - $1608.00 Fundraising expenses - $0.00 ALLIANCE FOR CELL THERAPY NOW 300 NEW JERSEY AVENUE NW Ste 900 Washington DC 20001 475183080 Advocacy DC 501c6 N/A false false false false false false false false false false false false false false false false false false false false